GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Pozen Inc. (POZN) President, CEO and Chairman, 10% Owner John R Plachetka sells 12,500 Shares

August 12, 2009 | About:
10qk

President, CEO and Chairman, 10% Owner of Pozen Inc. (POZN) John R Plachetka sells 12,500 shares of POZN on 08/10/2009 at an average price of $7.45 a share.

Pozen Inc. is pharmaceutical development company committed to building a portfolio of products with significant commercial potential in select therapeutic areas. Its initial area of focus is migraine where the company have built a portfolio of four product candidates through a combination of innovation and in-licensing. Its lead product candidate is MT 100 which the company is developing as an oral first-line therapy for the treatment of migraine. Pozen Inc. has a market cap of $217.9 million; its shares were traded at around $7.31 with and P/S ratio of 3.3.

Recent Trades of Pozen Inc. by CEO:


  • Sell: President, CEO and Chairman, 10% Owner John R Plachetka sold 12,500 shares of POZN stock on 08/03/2009 at the average price of $7.68; the price of the stock has decreased by 4.82% since.


Recent Trades of Pozen Inc. by Directors and Officers:


  • Sell: VP, Finance and Administration John E Barnhardt sold 10,000 shares of POZN stock on 07/15/2009 at the average price of $7.58; the price of the stock has decreased by 3.56% since.



Rating: 2.5/5 (4 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide